Page last updated: 2024-09-05

erlotinib hydrochloride and maytansine

erlotinib hydrochloride has been researched along with maytansine in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (maytansine)	Trials (maytansine)	Recent Studies (post-2010) (maytansine)
4,353	786	3,033	815	96	592

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cosmai, L; Gallieni, M; Porta, C	1

Reviews

1 review(s) available for erlotinib hydrochloride and maytansine

Article	Year
Renal toxicity of anticancer agents targeting HER2 and EGFR. Journal of nephrology, 2015, Volume: 28, Issue:6 Topics: Acute Kidney Injury; Ado-Trastuzumab Emtansine; Afatinib; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lapatinib; Maytansine; Neoplasms; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Renal Dialysis; Renal Insufficiency, Chronic; Trastuzumab	2015

Article

Year

Renal toxicity of anticancer agents targeting HER2 and EGFR.

Journal of nephrology, 2015, Volume: 28, Issue:6

Topics: Acute Kidney Injury; Ado-Trastuzumab Emtansine; Afatinib; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lapatinib; Maytansine; Neoplasms; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Renal Dialysis; Renal Insufficiency, Chronic; Trastuzumab

2015